DOCSLIB.ORG

English → Spanish → English

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
English → Spanish → English Inglés → Español - A - Acetorphine Acetorfina Acetorphine hydrochloride Clorhidrato de acetorfina Acetyl-alpha-methylfentanyl Acetil-alfa-metilfentanilo Acetyldihydrocodeine Acetildihidrocodeína Acetyldihydrocodeine hydrochloride Clorhidrato de acetildihidrocodeína Acetylmethadol Acetilmetadol Alfentanil Alfentanilo Alfentanil hydrochloride Clorhidrato de alfentanilo Allobarbital Alobarbital Allobarbital-aminophenazone Alobarbital-aminofenazona Allylprodine Alilprodina Allylprodine hydrochloride Clorhidrato de alilprodina Alphacetylmethadol Alfacetilmetadol Alphacetylmethadol hydrochloride Clorhidrato de alfacetilmetadol Alphameprodine Alfameprodina Alphamethadol Alfametadol Alpha-methylfentanyl Alfa-metilfentanilo Alpha-methylfentanyl hydrochloride Clorhidrato de alfa-metilfentanilo Alpha-methylthiofentanyl Alfa-metiltiofentanilo Alpha-methylthiofentanyl hydrochloride Clorhidrato de alfa-metiltiofentanilo Alphaprodine Alfaprodina Alphaprodine hydrochloride Clorhidrato de alfaprodina Alprazolam Alprazolam Amfepramone Anfepramona Amfepramone glutamate Glutamato de anfepramona Amfepramone hydrochloride Clorhidrato de anfepramona Amfepramone resinate Resinato de anfepramona Amfetamine Anfetamina Amfetamine acetylsalicylate Acetilsalicilato de anfetamina Amfetamine adipate Adipato de anfetamina Amfetamine p-aminophenylacetate p-aminofenilacetato de anfetamina Amfetamine aspartate Aspartato de anfetamina Amfetamine (4-chlorophenoxy) acetate 4-clorofenoxiacetato de anfetamina Amfetamine hydrochloride Clorhidrato de anfetamina Amfetamine pentobarbiturate Pentobarbiturato de anfetamina Amfetamine phosphate Fosfato de anfetamina Amfetamine resinate Resinato de anfetamina Amfetamine sulfate Sulfato de anfetamina Amfetamine tannate Tanato de anfetamina Amfetamine tartrate Tartrato de anfetamina Amineptine Amineptina Amineptine hydrochloride Clorhidrato de amineptina Aminorex Aminorex Aminorex fumarate Fumarato de aminorex Aminorex hydrochloride Clorhidrato de aminorex Amobarbital Amobarbital Amobarbital resinate Resinato de amobarbital Amobarbital sodium Amobarbital sódico Anileridine Anileridina Anileridine dihydrochloride Diclorhidrato de anileridina Anileridine phosphate Fosfato de anileridina 547 Inglés → Español - B - Barbital Barbital Barbital calcium Barbital cálcico Barbital magnesium Barbital magnésico Barbital sodium Barbital sódico Benzethidine Bencetidina Benzethidine hydrobromide Bromhidrato de bencetidina Benzethidine hydrochloride Clorhidrato de bencetidina Benzfetamine Benzfetamina Benzfetamine hydrochloride Clorhidrato de benzfetamina Benzylmorphine Bencilmorfina Benzylmorphine hydrochloride Clorhidrato de bencilmorfina Benzylmorphine methylsulfonate Metilsulfonato de bencilmorfina Betacetylmethadol Betacetilmetadol Beta-hydroxyfentanyl Beta-hidroxifentanilo Beta-hydroxyfentanyl hydrochloride Clorhidrato de beta-hidroxifentanilo Beta-hydroxy-3-methylfentanyl Beta-hidroxi-3-metilfentanilo Beta-hydroxy-3-methylfentanyl hydrochloride Clorhidrato de beta-hidroxi-3-metilfentanilo (+)-cis-beta-hydroxy-3-methylfentanyl Clorhidrato de (+)-cis-beta-hidroxi-3- hydrochloride · ¼ H2O metilfentanilo · ¼ H2O Betameprodine Betameprodina Betamethadol Betametadol Betaprodine Betaprodina Betaprodine hydrochloride Clorhidrato de betaprodina Bezitramide Becitramida Brolamfetamine (DOB) Brolanfetamina (DOB) Brolamfetamine hydrochloride Clorhidrato de brolanfetamina Bromazepam Bromazepam Brotizolam Brotizolam Buprenorphine Buprenorfina Buprenorphine hydrochloride Clorhidrato de buprenorfina Butalbital Butalbital Butobarbital Butobarbital - C - Camazepam Camazepam Cannabis Cannabis Cannabis oil Aceite de cannabis Cannabis resin Resina de cannabis Cathine Catina Cathine hydrochloride Clorhidrato de catina Cathine phenobarbital Catina fenobarbital Cathine resinate Resinato de catina Cathine sulfate Sulfato de catina Cathinone Catinona Cathinone hydrochloride Clorhidrato de catinona 2C-B 2C-B 2C-B hydrochloride Clorhidrato de 2C-B Chlordiazepoxide Clordiazepóxido Chlordiazepoxide dibunate Dibunato de clordiazepóxido Chlordiazepoxide hydrochloride Clorhidrato de clordiazepóxido Clobazam Clobazam 548 Inglés → Español Clonazepam Clonazepam Clonitazene Clonitaceno Clonitazene hydrochloride Clorhidrato de clonitaceno Clonitazene methylsulfonate Metilsulfonato de clonitaceno Clorazepate Clorazepato Clorazepate dipotassium Clorazepato dipotásico Clorazepate monopotassium Clorazepato monopotásico Clotiazepam Clotiazepam Cloxazolam Cloxazolam Coca leaf Hoja de coca Cocaine Cocaína Cocaine benzoate Benzoato de cocaína Cocaine borate Borato de cocaína Cocaine citrate Citrato de cocaína Cocaine formate Formiato de cocaína Cocaine hydriodide Yodhidrato de cocaína Cocaine hydrobromide Bromhidrato de cocaína Cocaine hydrochloride Clorhidrato de cocaína Cocaine lactate Lactato de cocaína Cocaine nitrate Nitrato de cocaína Cocaine salicylate Salicilato de cocaína Cocaine sulfate Sulfato de cocaína Cocaine tartrate Tartrato de cocaína d-cocaine d-cocaína Codeine Codeína Codeine acetate Acetato de codeína Codeine camphosulfonate Canfosulfonato de codeína Codeine citrate Citrato de codeína Codeine cyclohexenylethylbarbiturate Ciclohexeniletilbarbiturato de codeína Codeine cyclopentenylallylbarbiturate Ciclopentenilalilbarbiturato de codeína Codeine diallylbarbiturate Dialilbarbiturato de codeína Codeine diethylbarbiturate Dietilbarbiturato de codeína Codeine glucouronide Glucuronida de codeína Codeine hydriodide Yodhidrato de codeína Codeine hydrobromide Bromhidrato de codeína Codeine hydrochloride Clorhidrato de codeína Codeine methylbromide Bromometilato de codeína Codeine phenylethylbarbiturate Feniletilbarbiturato de codeína Codeine phosphate Fosfato de codeína Codeine resinate Resinato de codeína Codeine salicylate Salicilato de codeína Codeine sulfate Sulfato de codeína Codeine-N-oxide N-oxicodeína Codeine-N-oxide hydrochloride Clorhidrato de N-oxicodeína Codoxime Codoxima Concentrate of poppy straw Concentrado de paja de adormidera Cyclobarbital Ciclobarbital Cyclobarbital calcium Ciclobarbital cálcico - D - Delorazepam Delorazepam Desomorphine Desomorfina Desomorphine hydrobromide Bromhidrato de desomorfina 549 Inglés → Español Desomorphine hydrochloride Clorhidrato de desomorfina Desomorphine sulfate Sulfato de desomorfina DET DET Diethyltryptamine hydrochloride Clorhidrato de dietiltriptamina Dexamfetamine Dexanfetamina Dexamfetamine adipate Adipato de dexanfetamina Dexamfetamine carboxymethylcellulose Dexanfetamina carboximetilcelulosa Dexamfetamine hydrochloride Clorhidrato de dexanfetamina Dexamfetamine pentobarbiturate Pentobarbiturato de dexanfetamina Dexamfetamine phosphate Fosfato de dexanfetamina Dexamfetamine resinate Resinato de dexanfetamina Dexamfetamine saccharate Sacarato de dexanfetamina Dexamfetamine sulfate Sulfato de dexanfetamina Dexamfetamine tannate Tanato de dexanfetamina Dexamfetamine tartrate Tartrato de dexanfetamina Dextromoramide Dextromoramida Dextromoramide hydrochloride Clorhidrato de dextromoramida Dextromoramide tartrate Tartrato de dextromoramida Dextropropoxyphene Dextropropoxifeno Dextropropoxyphene hydrochloride Clorhidrato de dextropropoxifeno Dextropropoxyphene napsylate Napsilato de dextropropoxifeno Dextropropoxyphene resinate Resinato de dextropropoxifeno Diampromide Diampromida Diampromide sulfate Sulfato de diampromida Diazepam Diazepam Diethylthiambutene Dietiltiambuteno Diethylthiambutene hydrochloride Clorhidrato de dietiltiambuteno Difenoxin Difenoxina Difenoxin hydrochloride Clorhidrato de difenoxina Dihydrocodeine Dihidrocodeína Dihydrocodeine bitartrate Bitartrato de dihidrocodeína Dihydrocodeine hydrochloride Clorhidrato de dihidrocodeína Dihydrocodeine phosphate Fosfato de dihidrocodeína Dihydrocodeine resinate Resinato de dihidrocodeína Dihydrocodeine thiocyanate Tiocianato de dihidrocodeína Dihydroetorphine Dihidroetorfina Dihydromorphine Dihidromorfina Dihydromorphine hydriodide Yodhidrato de dihidromorfina Dihydromorphine hydrochloride Clorhidrato de dihidromorfina Dihydromorphine picrate Picrato de dihidromorfina Dimenoxadol Dimenoxadol Dimenoxadol hydrochloride Clorhidrato de dimenoxadol Dimepheptanol Dimefeptanol Dimepheptanol hydrochloride Clorhidrato de dimefeptanol 2,5-dimethoxyamfetamine (DMA) 2,5-dimetoxianfetamina (DMA) 2,5-dimethoxyamfetamine hydrochloride Clorhidrato de 2,5-dimetoxianfetamina 2,5-dimethoxy-4-ethylamfetamine (DOET) 2,5-dimetoxi-4-etilanfetamina (DOET) 2,5-dimethoxy-4-ethylamfetamine hydrochloride Clorhidrato de 2,5-dimetoxi-4-etilanfetamina Dimethylthiambutene Dimetiltiambuteno Dimethylthiambutene hydrochloride Clorhidrato de dimetiltiambuteno Dioxaphetyl butyrate Butirato de dioxafetilo Dioxaphetyl butyrate hydrochloride Clorhidrato de butirato de dioxafetilo Diphenoxylate Difenoxilato Diphenoxylate hydrochloride Clorhidrato de difenoxilato 550 Inglés → Español Dipipanone Dipipanona Dipipanone hydrobromide Bromhidrato de dipipanona Dipipanone hydrochloride Clorhidrato de dipipanona DMHP DMHP DMT DMT Dimethyltryptamine hydrochloride Clorhidrato de dimetiltriptamina Dimethyltryptamine methyliodide Metilyoduro de dimetiltriptamina Dronabinol Dronabinol Drotebanol Drotebanol - E - Ecgonine Ecgonina Ecgonine benzoylester Éster benzoílico de la ecgonina Ecgonine benzoylethylester Éster benzoiletílico de la ecgonina Ecgonine cinnamoylmethylester Éster cinnamoilmetílico de la ecgonina Ecgonine 2,6-dimethylbenzoylmethylester Éster 2-6 dimetilbenzoilmetílico de la ecgonina Ecgonine hydrochloride Clorhidrato de ecgonina Ecgonine methylester Éster metílico de la ecgonina Ecgonine
Load more

Recommended publications
  • Minnesota Statutes 1979 Supplement
    MINNESOTA STATUTES 1979 SUPPLEMENT 152.01 PROHIBITED DRUGS CHAPTER 152. PROHIBITED DRUGS Sec. 152.01 Definitions. 152.02 Schedules of controlled substances; admin­ istration of chapter. 152.01 Definitions. [For text of subds 1 to 8, see M.S.1978] Subd. 9. Marijuana. "Marijuana" means all parts of the plant of any species of the genus Cannabis, including all agronomical varieties, whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin, but shall not include the mature stalks of such plant, fiber from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mix­ ture, or preparation of such mature stalks, except the resin extracted therefrom, fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination. [For text of subds 10 to 17, see M.S.1978] [ 1979 c 157 s 1 ] 152.02 Schedules of controlled substances; administration of chapter. [For text of subd 1, see M.S.1978) Subd. 2. The following items are listed in Schedule I: (1) Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the exis­ tence of such isomers, esters, ethers and salts is possible within the specific chemical des­ ignation: Acetylmethadol; Allylprodine; Alphacetylmethadol; Alphameprodine; Alpham- ethadol; Benzethidine; Betacetylmethadol; Betameprodine; Betamethadol; Betaprodine; Clonitazene; Dextromoramide; Dextrorphan; Diampromide; Diethyliambutene; Dime- noxadol; Dimepheptanol; Dimethyliambutene; Dioxaphetyl butyrate; Dipipanone; Ethylmethylthiambutene; Etonitazene; Etoxeridine; Furethidine; Hydroxypethidine; Ke- tobemidone; Levomoramide; Levophenacylmorphan; Morpheridine; Noracymethadol; Norlevorphanol; Normethadone; Norpipanone; Phenadoxone; Phenampromide; Pheno- morphan; Phenoperidine; Piritramide; Proheptazine; Properidine; Racemoramide; Tri­ meperidine.
    [Show full text]
  • Metabolic-Hydroxy and Carboxy Functionalization of Alkyl Moieties in Drug Molecules: Prediction of Structure Influence and Pharmacologic Activity
    molecules Review Metabolic-Hydroxy and Carboxy Functionalization of Alkyl Moieties in Drug Molecules: Prediction of Structure Influence and Pharmacologic Activity Babiker M. El-Haj 1,* and Samrein B.M. Ahmed 2 1 Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, University of Science and Technology of Fujairah, Fufairah 00971, UAE 2 College of Medicine, Sharjah Institute for Medical Research, University of Sharjah, Sharjah 00971, UAE; [email protected] * Correspondence: [email protected] Received: 6 February 2020; Accepted: 7 April 2020; Published: 22 April 2020 Abstract: Alkyl moieties—open chain or cyclic, linear, or branched—are common in drug molecules. The hydrophobicity of alkyl moieties in drug molecules is modified by metabolic hydroxy functionalization via free-radical intermediates to give primary, secondary, or tertiary alcohols depending on the class of the substrate carbon. The hydroxymethyl groups resulting from the functionalization of methyl groups are mostly oxidized further to carboxyl groups to give carboxy metabolites. As observed from the surveyed cases in this review, hydroxy functionalization leads to loss, attenuation, or retention of pharmacologic activity with respect to the parent drug. On the other hand, carboxy functionalization leads to a loss of activity with the exception of only a few cases in which activity is retained. The exceptions are those groups in which the carboxy functionalization occurs at a position distant from a well-defined primary pharmacophore. Some hydroxy metabolites, which are equiactive with their parent drugs, have been developed into ester prodrugs while carboxy metabolites, which are equiactive to their parent drugs, have been developed into drugs as per se.
    [Show full text]
  • Did Internet-Purchased Diet Pills Cause Serotonin Syndrome?
    Did Internet-purchased diet pills cause serotonin syndrome? Phentermine also may have increased patient’s neuroleptic malignant syndrome risk s. G, age 28, presents to a tertiary® careDowden hospital Health Media with altered mental status. Six weeks ago she Mstarted taking phentermine, 37.5 mg/d, to lose weight. Her body mass indexCopyright is 24 kg/mFor2 (normal personal range), use only and she obtained the stimulant agent via the Internet. Her family reports Ms. G was very busy in the past week, staying up until 2 AM cleaning. They say she also was irritable with her 5-year-old son. Two days ago, Ms. G complained of fatigue and nausea without emesis. She went to bed early and did not awaken the next morning. Her sister found her in bed, minimally re- DIONISI sponsive to verbal stimuli, and brought her to the hospital. Patients have used phentermine as a weight-reducing IMAGES/SANDRA GETTY agent since the FDA approved this amphetamine-like © compound in 1960.1 Phentermine’s mechanism of ac- tion is thought to involve dopaminergic, noradrenergic, Kyoung Bin Im, MD and serotonergic effects.2 Stimulation of norepineph- Chief resident Internal medicine and psychiatry combined residency program rine (NE) release is its most potent effect, followed Departments of internal medicine and psychiatry by NE reuptake inhibition, stimulation of dopamine Jess G. Fiedorowicz, MD (DA) release, DA reuptake inhibition, stimulation of Associate in psychiatry serotonin (5-HT) release, and 5-HT reuptake inhibition Department of psychiatry (weak).3 Roy J. and Lucille A. Carver College of Medicine Because phentermine could in theory cause serotonin 4 University of Iowa syndrome, its use is contraindicated with monoamine Iowa City oxidase inhibitors (MAOIs) and not recommended with selective serotonin reuptake inhibitors (SSRIs).5 One case report describes an interaction between fl uox- etine and phentermine that appears consistent with se- rotonin syndrome.6 We are aware of no case reports of Current Psychiatry serotonin syndrome caused by phentermine alone.
    [Show full text]
  • Screening/Spot Test of Narcotics
    Indian Journal of Forensic and Community Medicine 2020;7(4):160–165 Content available at: https://www.ipinnovative.com/open-access-journals Indian Journal of Forensic and Community Medicine Journal homepage: https://www.ipinnovative.com/journals/IJFCM Review Article Screening/spot test of narcotics A K Jaiswal1,*, Kamna Sharma2, Rohit Kanojia3, Sally Lukose4 1Dept. of Forensic Medicine & Toxicology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India 2Galgotias University, Greater Noida, Uttar Pradesh, India 3Dept. of Chemistry, University of Delhi, New Delhi, India 4CTM-IRTE, Faridabad, Haryana, India ARTICLEINFO ABSTRACT Article history: Narcotics are the substances used to treat moderate to severe pain. They could be natural like opiates such Received 25-11-2020 as morphine, codeine etc., synthetic like fentanyl, methadone etc., and semi-synthetic like oxycodone, Accepted 02-12-2020 hydrocodone etc. These drugs act as pain relievers, induces the state of stupor or sleep, and increase Available online 08-01-2021 the physical dependence on them. In forensic autopsy case, the forensic pathologist may require a complete toxicological investigation for different poisons including stimulants. In India, Forensic Science Laboratories run by Government under the Home ministry usually carry out this. The samples must be Keywords: analysed by the forensic toxicologist/chemists/scientist. This article deals with the screening/spot test for Narcotics narcotics. It attempts to simplify the standard procedures in a step-wise manner, which can be of handy Screening reference for the forensic toxicologist. Spot test Drugs © This is an open access article distributed under the terms of the Creative Commons Attribution Opioids etc License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
    [Show full text]
  • Federal Register/Vol. 85, No. 36/Monday, February 24, 2020
    10466 Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices Controlled substance Drug code Schedule Alphamethadol ................................................................................................................................................................. 9605 I Benzethidine .................................................................................................................................................................... 9606 I Betacetylmethadol ........................................................................................................................................................... 9607 I Clonitazene ...................................................................................................................................................................... 9612 I Diampromide ................................................................................................................................................................... 9615 I Diethylthiambutene .......................................................................................................................................................... 9616 I Dimethylthiambutene ....................................................................................................................................................... 9619 I Ketobemidone .................................................................................................................................................................
    [Show full text]
  • 2020 Kansas Statutes
    2020 Kansas Statutes 65-4105. Substances included in schedule I. (a) The controlled substances listed in this section are included in schedule I and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it. (b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation: (1) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide) 9821 (2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N- phenylacetamide) 9815 (3) Acetylmethadol 9601 (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; acryloylfentanyl) 9811 (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) 9551 (6) Allylprodine 9602 (7) Alphacetylmethadol 9603(except levo-alphacetylmethadol also known as levo- alpha-acetylmethadol, levomethadyl acetate or LAAM) (8) Alphameprodine 9604 (9) Alphamethadol 9605 (10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) 9814 (11) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N- phenylpropanamide) 9832 (12) Benzethidine 9606 (13) Betacetylmethadol 9607 (14) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N- phenylpropanamide) 9830 (15) Beta-hydroxy-3-methylfentanyl (other
    [Show full text]
  • (19) United States (12) Patent Application Publication (10) Pub
    US 20130289061A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0289061 A1 Bhide et al. (43) Pub. Date: Oct. 31, 2013 (54) METHODS AND COMPOSITIONS TO Publication Classi?cation PREVENT ADDICTION (51) Int. Cl. (71) Applicant: The General Hospital Corporation, A61K 31/485 (2006-01) Boston’ MA (Us) A61K 31/4458 (2006.01) (52) U.S. Cl. (72) Inventors: Pradeep G. Bhide; Peabody, MA (US); CPC """"" " A61K31/485 (201301); ‘4161223011? Jmm‘“ Zhu’ Ansm’ MA. (Us); USPC ......... .. 514/282; 514/317; 514/654; 514/618; Thomas J. Spencer; Carhsle; MA (US); 514/279 Joseph Biederman; Brookline; MA (Us) (57) ABSTRACT Disclosed herein is a method of reducing or preventing the development of aversion to a CNS stimulant in a subject (21) App1_ NO_; 13/924,815 comprising; administering a therapeutic amount of the neu rological stimulant and administering an antagonist of the kappa opioid receptor; to thereby reduce or prevent the devel - . opment of aversion to the CNS stimulant in the subject. Also (22) Flled' Jun‘ 24’ 2013 disclosed is a method of reducing or preventing the develop ment of addiction to a CNS stimulant in a subj ect; comprising; _ _ administering the CNS stimulant and administering a mu Related U‘s‘ Apphcatlon Data opioid receptor antagonist to thereby reduce or prevent the (63) Continuation of application NO 13/389,959, ?led on development of addiction to the CNS stimulant in the subject. Apt 27’ 2012’ ?led as application NO_ PCT/US2010/ Also disclosed are pharmaceutical compositions comprising 045486 on Aug' 13 2010' a central nervous system stimulant and an opioid receptor ’ antagonist.
    [Show full text]
  • Pharmacology and Toxicology of Amphetamine and Related Designer Drugs
    Pharmacology and Toxicology of Amphetamine and Related Designer Drugs U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol Drug Abuse and Mental Health Administration Pharmacology and Toxicology of Amphetamine and Related Designer Drugs Editors: Khursheed Asghar, Ph.D. Division of Preclinical Research National Institute on Drug Abuse Errol De Souza, Ph.D. Addiction Research Center National Institute on Drug Abuse NIDA Research Monograph 94 1989 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 Pharmacology and Toxicology of Amphetamine and Related Designer Drugs ACKNOWLEDGMENT This monograph is based upon papers and discussion from a technical review on pharmacology and toxicology of amphetamine and related designer drugs that took place on August 2 through 4, 1988, in Bethesda, MD. The review meeting was sponsored by the Biomedical Branch, Division of Preclinical Research, and the Addiction Research Center, National Institute on Drug Abuse. COPYRIGHT STATUS The National Institute on Drug Abuse has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder’s permission is required. All other matieral in this volume except quoted passages from copyrighted sources is in the public domain and may be used or reproduced without permission from the Institute or the authors.
    [Show full text]
  • CONTROLLED SUBSTANCE, DRUG, DEVICE and COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun
    CONTROLLED SUBSTANCE, DRUG, DEVICE AND COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun. 23, 2011, P.L. 36, No. 7 Cl. 35 Session of 2011 No. 2011-7 SB 1006 AN ACT Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for Schedule I controlled substances. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Section 4(1) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, amended November 24, 1999 (P.L.894, No.55), is amended to read: Section 4. Schedules of Controlled Substances.--The following schedules include the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. (1) Schedule I--In determining that a substance comes within this schedule, the secretary shall find: a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. The following controlled substances are included in this schedule: (i) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation: 1.
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0024006 A1 Simon (43) Pub
    US 2004.0024006A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0024006 A1 Simon (43) Pub. Date: Feb. 5, 2004 (54) OPIOID PHARMACEUTICAL May 30, 1997, now abandoned, and which is a COMPOSITIONS continuation-in-part of application No. 08/643,775, filed on May 6, 1996, now abandoned. (76) Inventor: David Lew Simon, Mansfield Center, CT (US) Publication Classification Correspondence Address: (51) Int. Cl. ................................................ A61K 31/485 David L. Simon (52) U.S. Cl. .............................................................. 514/282 P.O. Box 618 100 Cemetery Road (57) ABSTRACT Mansfield Center, CT 06250 (US) The invention is directed in part to dosage forms comprising a combination of an analgesically effective amount of an (21) Appl. No.: 10/628,089 opioid agonist analgesic and a neutral receptor binding agent or a partial mu-opioid agonist, the neutral receptor binding (22) Filed: Jul. 25, 2003 agent or partial mu-opioid agonist being included in a ratio Related U.S. Application Data to the opioid agonist analgesic to provide a combination product which is analgesically effective when the combina (63) Continuation-in-part of application No. 10/306,657, tion is administered as prescribed, but which is leSS analge filed on Nov. 27, 2002, which is a continuation-in-part Sically effective or less rewarding when administered in of application No. 09/922,873, filed on Aug. 6, 2001, excess of prescription. Preferably, the combination product now Pat. No. 6,569,866, which is a continuation-in affects an opioid dependent individual differently from an part of application No. 09/152,834, filed on Sep.
    [Show full text]
  • Drugs of Abuseon September Archived 13-10048 No
    U.S. DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION WWW.DEA.GOV 9, 2014 on September archived 13-10048 No. v. Stewart, in U.S. cited Drugs of2011 Abuse EDITION A DEA RESOURCE GUIDE V. Narcotics WHAT ARE NARCOTICS? Also known as “opioids,” the term "narcotic" comes from the Greek word for “stupor” and originally referred to a variety of substances that dulled the senses and relieved pain. Though some people still refer to all drugs as “narcot- ics,” today “narcotic” refers to opium, opium derivatives, and their semi-synthetic substitutes. A more current term for these drugs, with less uncertainty regarding its meaning, is “opioid.” Examples include the illicit drug heroin and pharmaceutical drugs like OxyContin®, Vicodin®, codeine, morphine, methadone and fentanyl. WHAT IS THEIR ORIGIN? The poppy papaver somniferum is the source for all natural opioids, whereas synthetic opioids are made entirely in a lab and include meperidine, fentanyl, and methadone. Semi-synthetic opioids are synthesized from naturally occurring opium products, such as morphine and codeine, and include heroin, oxycodone, hydrocodone, and hydromorphone. Teens can obtain narcotics from friends, family members, medicine cabinets, pharmacies, nursing 2014 homes, hospitals, hospices, doctors, and the Internet. 9, on September archived 13-10048 No. v. Stewart, in U.S. cited What are common street names? Street names for various narcotics/opioids include: ➔ Hillbilly Heroin, Lean or Purple Drank, OC, Ox, Oxy, Oxycotton, Sippin Syrup What are their forms? Narcotics/opioids come in various forms including: ➔ T ablets, capsules, skin patches, powder, chunks in varying colors (from white to shades of brown and black), liquid form for oral use and injection, syrups, suppositories, lollipops How are they abused? ➔ Narcotics/opioids can be swallowed, smoked, sniffed, or injected.
    [Show full text]